Cargando…
Current Perspectives: Evidence to Date on BTK Inhibitors in the Management of Multiple Sclerosis
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system leading to demyelination and neurodegeneration. Basic and translational studies have shown that B cells and myeloid cells are critical players for the development and course of the disease. Bruton’s tyrosine kina...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553159/ https://www.ncbi.nlm.nih.gov/pubmed/36238195 http://dx.doi.org/10.2147/DDDT.S348129 |